Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Delcath Systems Inc.
ClinicalTrials.gov Identifier:
NCT00096083
First received: November 9, 2004
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)